Drug Interactions with Methadone
Presse Med 27:1381-1384, Schlatter,J.,et al, 1999

Herbal Remedies: Adverse Effects and Drug Interactions
Am Fam Physician 59:1239-1244, Cupp, M.J.,et al, 1999

Medically Induced Gingival Hyperplasia
Mayo Clin Proc 73:1196-1199, Meraw,S.J. &Sheridan,P.J., 1998

Gabapentin for the Symptomatic Treatment of Painful Neuropathy in Patients with Diabetes Mellitus,A Randomized Controlled Trial
JAMA 280:1831-1836, Backonja,M.,et al, 1998

Donepezil Improves Cognition & Global Function in Alzheimer Dis, 15-Week Doub-Blind, Plac-Contr Study
Arch Int Med 158:1021-1031, 9411998., Rogers,S.L.,et al, 1998

HIV-Protease Inhibitors
NEJM 338:1281-1292, Flexner,C., 1998

Fiddleheads and the International Normalized Ratio
NEJM 338:1550, Bartle,W.R.&Ferland,G., 1998

Drug-Induced Pseudolymphoma Secondary to Lamotrigine
Neurol 50:1509-1510, Pathak,P.&McLachlan,R.S., 1998

Hyponatremia Due to Sodium Valproate
Ann Neurol 43:265-267, Branten,A.J.W.,et al, 1998

Randomized Prospective Study of Early Discontinuation of Antiepileptic Drugs in Children with epilepsy
Neurol 50:724-730, Peters,A.C.B.,et al, 1998

Vigabatrin-Associated Retinal Cone System Dysfunction, Electroretinogram & Ophthalmol Findings
Neurol 50:614-618, Krauss,G.L.,et al, 1998

Clopidogrel for Reduction of Atherosclerotic Events
The Medical Letter 40:59-60, , 1998

Lamotrigine-Associated Anticonvulsant Hypersentivitiy Syndrome
Neurol 51:1171-1175, Schlienger,R.G.,et al, 1998

New Antiepileptic Drugs
Arch Neurol 55:1181-1183, Bourgeois,B.F.D., 1998

Acute Encephalopathy Associated with Vigabatrin Monotherapy in Patients with Mild Renal Failure
Neurol 51:314-315, Ifergane,G.,et al, 1998

Acute, Drug-Induced, Life-Threatening Neurological Syndromes
The Neurologist 4:196-210, Richard,I.H., 1998

Serotonin Syndrome Induced by Transitioning from Phenelzine to Venlafaxine:four Patient Reports
Neurol 51:274-276, Diamond,S.,et al, 1998

Use of Anticonvul in Eclampsia & Pre-Eclampsia:Survey of Obstetr in the UK & Rep of Ireland
BMJ 316:975-976, Gulmezoglu,A.M.&Duley,L., 1998

Acute Delirium After Withdrawal of Amantadine in Parkinson's Disease
Neurol 50:1456-1458, Factor,S.A.,et al, 1998

Investig of PDRG of UK into Excess Mortality Seen/Comb Levodopa & Selegiline Trmt in Pts with Early, Mild Parkinson's Dis
BMJ 316:1191-1196, Ben-Shlomo,Y.,et al, 1998

Tolcapone for Parkinson's Disease
The Medical Letter 40:60-61, , 1998

Catechol-O-Methyltransferase Inhibitors for Treatment of Parkinson's Disease
Lancet 351:1221-1222, Nutt,J.G., 1998

Antiepileptics and Blood Dyscrasias: A Cohort Study
Pharmacotherapy 18:1277-1283, Blackburn,S.C.F.,et al, 1998

A 24-Week, Double-Blind, Placebo-Controlled Trial of Donepezil in Pts with Alzheimer's Disease
Neurol 50:136-145, Rogers,S.,et al, 1998

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation
JAMA 279:657-662, 7021998., Hylek,E.M.,et al, 1998

Risk of Serious Cutaneous Disorders after Initiation of Use of Phenytoin, Carbamazepine, or Sodium Valproate
Neurol 49:542-546, Tennis,P.&Stern,R.S., 1997

Choreoathetosis as a Side Effect of Gabapentin Therapy in Severely Neurologically Impaired Patients
Arch Neurol 54:910-912, Chudnow,R.S.,et al, 1997

Gabapentin and Cognition:A Double Blind, Dose Ranging, Placebo Controlled Study in Refractory Epilepsy
JNNP 62:372-376, Leach,J.P.,et al, 1997

Incontinence During Treatment with Gabapentin
Neurol 48:1467-1468, Gil-Nagel,A.,et al, 1997

Cognitive Recovery Instead of Decline After Acute Encephalitis:A Prospective Follow Up Study
JNNP 63:222-227, Hokkanen,L.&Launes,J., 1997

Gabapentin for Idiopathic Trigeminal Neuralgia:Report of Two Cases
Neurol 48:1467, Sist,T.,et al, 1997

Butorphanol (Stadol) :A Study in Problems of Current Drug Information and Control
Neurol 48:1156-1160, Fisher,M.A.&Glass,S., 1997

Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease
Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997

Anemia Associated with Lamotrigine
Neurol 49:306-307, Esfahani,F.E.&Dasheiff,R.M., 1997

Carbamazepine and Fatal Eosinophilic Myocarditis
NEJM 336:878-879, Salzman,M.B.,et al, 1997

Color Vision Test for Early Detection of Antiepileptic Drug Toxicity
Neurol 48:1394-1397, Bayer,A.U.,et al, 1997

Tizanidine for Spasticity
The Medical Letter 39:62, , 1997

Pharmacological Management of Alcohol Withdrawal
JAMA 278:144-151, Mayo-Smith,M.F., 1997

The Alcohol Withdrawal Syndrome
Lancet 349:1897-1900, Hall,W.&Zador,D., 1997

Severe Persistent Visual Field Constriction Associated with Vigabatrin
BMJ 14:180-181, Eke,T.,et al, 1997

Gabapentin for Parkinsonism:A Double-Blind Placebo-Controlled, Crossover Trial
Am J med 102:60-66, Olson,W.L.,et al, 1997

Drugs and Myasthenia Gravis, An Update
Arch Int Med 157:399-408, Wittbrodt,E.T., 1997

Trihexyphenidyl Withdrawal Encephalopathy
Ann Neurol 41:133-134, Johkura,K.,et al, 1997

Serotonin Syndrome and the Combined Use of Deprenyl and An Antidepressant in Parkinson's Disease
Neurol 48:1070-1077, Richard,I.H.,et al, 1997

The Clinical Relevance of the Interaction Between Carbamazepine and Dextropropoxyphene in Elderly Patients in Gotenburg, Sweden
Europ J Clin Pharm 53:203-206, Bergendal,L.,et al, 1997

Extrapyramidal Side Effects with Low-Dose Risperidone
Can J Psychiatry 42:325-325, Brown, E.S., 1997

Exquisite Sensitivity of Paroxysmal Kinesigenic Choreoathetosis to Carbamazepine
Neurol 47:1104-1106, Wein,T.,et al, 1996

Riluzole
Lancet 348:795-799, Wokke,J., 1996

Treatment of Rasmussen's Syndrome with Ganciclovir
Neurol 47:925-928, McLachlan,R.S.,et al, 1996

Gabapentin Interaction with Felbamate
Neurol 47:1106, Hussein,G.,et al, 1996